Search research articles
Contact Us
Filters
Showing results (1-10 of 117) with videos related to
Page
of 12
Sort By:
International Journal of Antimicrobial Agents
|
June 30, 2009
Treatment options for skin and soft tissue infections: 'oldies but goldies'
Serhat Unal
Trials
|
April 14, 2021
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial
Murat Akova, Serhat Unal
Antiviral Therapy
|
January 17, 2013
The challenges of hepatitis C diagnosis and the potential role of Stimmunology™ to address them
Tamar Jehuda-Cohen, Serhat Unal
International Journal of Antimicrobial Agents
|
March 12, 2004
Bacteraemia in Europe--antimicrobial susceptibility data from the MYSTIC surveillance programme
Serhat Unal, Robert Masterton, Herman Goossens
Mikrobiyoloji Bulteni
|
June 17, 2006
[Antimicrobial resistance of Neisseria gonorrhoeae strains isolated from sex workers in Ankara]
Pinar Zarakolu, Bülent Sakizligil, Serhat Unal
International Journal of Antimicrobial Agents
|
August 2, 2020
Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19
Emre Kara, Kutay Demirkan, Serhat Unal
Mikrobiyoloji Bulteni
|
April 13, 2007
[In vitro susceptibility of respiratory isolates of Streptococcus pneumoniae and Streptococcus pyogenes to telithromycin and 11 other antimicrobial agents: Turkish results of e-BASKETT-II surveillance study]
Deniz Gür, Lütfiye Mülazimoğlu, Serhat Unal, et al.
Mikrobiyoloji Bulteni
|
September 28, 2006
[Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)]
Pinar Zarakolu, Gülşen Hasçelik, Serhat Unal
Diagnostic Microbiology and Infectious Disease
|
December 20, 2005
Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004
Serhat Unal, Jose Angel Garcia-Rodriguez
Human Vaccines & Immunotherapeutics
|
September 27, 2016
Barriers to adult immunization and solutions: Personalized approaches
Devrim Emel Alici, Abdullah Sayiner, Serhat Unal
Page
of 12
Search research articles
Search
Showing results (1-10 of 117) with videos related to
Sort By:
Page
of 12
International Journal of Antimicrobial Agents
|
June 30, 2009
Treatment options for skin and soft tissue infections: 'oldies but goldies'
Serhat Unal
Trials
|
April 14, 2021
A randomized, double-blind, placebo-controlled phase III clinical trial to evaluate the efficacy and safety of SARS-CoV-2 vaccine (inactivated, Vero cell): a structured summary of a study protocol for a randomised controlled trial
Murat Akova, Serhat Unal
Antiviral Therapy
|
January 17, 2013
The challenges of hepatitis C diagnosis and the potential role of Stimmunology™ to address them
Tamar Jehuda-Cohen, Serhat Unal
International Journal of Antimicrobial Agents
|
March 12, 2004
Bacteraemia in Europe--antimicrobial susceptibility data from the MYSTIC surveillance programme
Serhat Unal, Robert Masterton, Herman Goossens
Mikrobiyoloji Bulteni
|
June 17, 2006
[Antimicrobial resistance of Neisseria gonorrhoeae strains isolated from sex workers in Ankara]
Pinar Zarakolu, Bülent Sakizligil, Serhat Unal
International Journal of Antimicrobial Agents
|
August 2, 2020
Recommendations for use of a hydroxychloroquine loading dose in patients with COVID-19
Emre Kara, Kutay Demirkan, Serhat Unal
Mikrobiyoloji Bulteni
|
April 13, 2007
[In vitro susceptibility of respiratory isolates of Streptococcus pneumoniae and Streptococcus pyogenes to telithromycin and 11 other antimicrobial agents: Turkish results of e-BASKETT-II surveillance study]
Deniz Gür, Lütfiye Mülazimoğlu, Serhat Unal, et al.
Mikrobiyoloji Bulteni
|
September 28, 2006
[Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)]
Pinar Zarakolu, Gülşen Hasçelik, Serhat Unal
Diagnostic Microbiology and Infectious Disease
|
December 20, 2005
Activity of meropenem and comparators against Pseudomonas aeruginosa and Acinetobacter spp. isolated in the MYSTIC Program, 2002-2004
Serhat Unal, Jose Angel Garcia-Rodriguez
Human Vaccines & Immunotherapeutics
|
September 27, 2016
Barriers to adult immunization and solutions: Personalized approaches
Devrim Emel Alici, Abdullah Sayiner, Serhat Unal
Page
of 12